Regeneron Pharmaceuticals Unusual Options Activity For May 25
Portfolio Pulse from Benzinga Insights
A whale has taken a bullish stance on Regeneron Pharmaceuticals (NASDAQ: REGN) with unusual options activity detected. 50% of investors opened trades with bullish expectations and 50% with bearish. Whales have been targeting a price range of $700 to $900 for REGN over the last 3 months.
May 25, 2023 | 8:19 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Unusual options activity detected for Regeneron Pharmaceuticals, with a whale taking a bullish stance. Target price range is $700 to $900.
The article highlights unusual options activity for Regeneron Pharmaceuticals, with a whale taking a noticeably bullish stance. This indicates that the investor expects the stock price to rise in the short term. The target price range of $700 to $900 also suggests a potential upside for the stock. Additionally, several analysts have maintained their Buy or Overweight ratings on REGN, further supporting the bullish sentiment.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100